1. Home
  2. M vs GRFS Comparison

M vs GRFS Comparison

Compare M & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Macy's Inc

M

Macy's Inc

HOLD

Current Price

$18.63

Market Cap

5.8B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.39

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
M
GRFS
Founded
1830
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.8B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
M
GRFS
Price
$18.63
$8.39
Analyst Decision
Hold
Hold
Analyst Count
13
2
Target Price
$20.09
$10.15
AVG Volume (30 Days)
7.6M
752.1K
Earning Date
05-27-2026
07-28-2022
Dividend Yield
4.23%
1.76%
EPS Growth
12.08
N/A
EPS
2.32
N/A
Revenue
$22,621,000,000.00
N/A
Revenue This Year
N/A
$4.69
Revenue Next Year
N/A
$6.49
P/E Ratio
$7.80
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$6.27
52 Week High
$24.41
$11.14

Technical Indicators

Market Signals
Indicator
M
GRFS
Relative Strength Index (RSI) 51.51 54.35
Support Level $16.55 $8.25
Resistance Level $18.71 $9.11
Average True Range (ATR) 0.68 0.21
MACD 0.18 0.11
Stochastic Oscillator 76.49 93.53

Price Performance

Historical Comparison
M
GRFS

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: